FDA Guidance for Industry: Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products and Other Interested Parties

Titel:
FDA Guidance for Industry: Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products and Other Interested Parties
Internet:
Herkunft/Verlag:

FDA

Inhalt:
This guidance provides recommendations to sponsors and other interested parties on the use of artificial intelligence (AI) to produce information or data intended to support regulatory decisionmaking regarding safety, effectiveness, or quality for drugs.5

Zurück